Healthcare Services

Nocturia Market Forecast 2026: Where the Industry Is Headed

February 27, 2026April 15, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the nocturia market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Nocturia Market?

The nocturia market size has shown strong growth in recent years. It is projected to increase from $3.1 billion in 2025 to $3.35 billion in 2026, at a compound annual growth rate (CAGR) of 8.0%. The growth observed in the past can be attributed to several factors including an aging population, a rise in the incidence of benign prostatic hyperplasia, increasing prevalence of urinary tract infections, the extensive use of diuretic medications, and limited early diagnostic awareness.

The nocturia market is anticipated to experience strong growth over the next few years, with its size projected to reach $4.51 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. This expansion during the forecast period is attributed to several factors, including the increasing demand for personalized treatment, the broader availability of home care therapies, rising healthcare expenditure, a heightened focus on sleep quality management, and improved access to urology specialists. Key trends observed in this period encompass a rising geriatric population alongside age-related urological disorders, an increasing prevalence of diabetes and metabolic disorders, growing awareness and diagnosis of lower urinary tract symptoms, a transition toward combination drug therapies, and the expansion of home-based nocturia management solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21232&type=smp

What Drivers Are Supporting Technological Adoption In The Nocturia Market?

The increasing occurrence of cardiovascular diseases is projected to stimulate the expansion of the nocturia market in the future. Cardiovascular diseases (CVDs) refer to a range of conditions that impact the heart and blood vessels, including issues like heart disease, stroke, and hypertension. The widespread nature of these diseases stems from factors such as an aging population, inactive lifestyles, unhealthy eating habits, smoking, excessive alcohol intake, obesity, high blood pressure, elevated cholesterol levels, diabetes, and genetic predispositions. Patients diagnosed with cardiovascular diseases frequently experience nocturia as a symptom, which in turn escalates the demand for diagnostic tools and treatment solutions. As the global prevalence of cardiovascular conditions continues to climb due to an aging demographic and unhealthy living choices, the need for effective nocturia management will similarly grow. For instance, in September 2025, figures from the British Heart Foundation, a UK-based charity, indicated that more than 7.6 million people across the UK—specifically over 4 million men and more than 3.6 million women—are currently living with cardiovascular disease. Projections further suggest that, driven by an aging population and improved survival rates, the number of affected individuals could increase by around 1 million by 2030 and by approximately 2 million by 2040. Therefore, the rising prevalence of cardiovascular diseases is a key factor driving the growth of the nocturia market.

What Segment Types Are Examined In The Nocturia Market?

The nocturia market covered in this report is segmented –

1) By Drug: Anticholinergic Drugs, Desmopressin, Antibiotics, Antispasmodic, Other Drugs

2) By Indication: Mixed Nocturia, Low Nocturnal Bladder Capacity, Nocturnal Polyuria, Global Polyuria

3) By Causes: Urological Infection, Tumor Of The Bladder, Diuretic Medications, Regular Alcohol Or Coffee, Liver Infection, Diabetes, Pregnancy, Other Causes

4) By End User: Hospitals, Home Care, Clinics

Subsegments:

1) By Anticholinergic Drugs: Oxybutynin, Tolterodine, Solifenacin, Darifenacin, Fesoterodine

2) By Desmopressin: Intranasal Desmopressin, Oral Desmopressin

3) By Antibiotics: Nitrofurantoin, Trimethoprim, Fosfomycin

4) By Antispasmodic: Hyoscine Butylbromide, Flavoxate

5) By Other Drugs: Alpha-Blockers, Beta-3 Agonists

How Are New Market Trends Shaping The Landscape Of The Nocturia Market?

Leading companies operating within the nocturia market are focusing on developing innovative products, such as orally disintegrating tablets, to enhance patient convenience and compliance. Orally disintegrating tablets (ODTs) are solid dosage forms that rapidly dissolve in the mouth without requiring water, making them ideal for patients who have difficulty swallowing. For instance, in July 2024, Adalvo Limited, a Malta-based pharmaceutical company, launched Desmopressin ODT in Europe to treat conditions that cause the body to lose too much fluid, such as central cranial diabetes insipidus. This synthetic form of vasopressin tablet treats diabetes insipidus, excessive thirst and urination, and bedwetting by mimicking the natural hormone and limiting the amount of water eliminated in urine. It is also utilized to manage bleeding in mild to moderate hemophilia A and von Willebrand disease by promoting the release of blood clotting factors.

Who Are The Primary Competitors In The Global Nocturia Market?

Major companies operating in the nocturia market are Pfizer Inc, Merck & Co. Inc, AbbVie Inc, Sanofi S.A, GlaxoSmithKline plc, Viatris Inc, Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd, Astellas Pharma Inc, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd, Ferring Pharmaceuticals A/S, Avadel Pharmaceuticals plc, UroGen Pharma Ltd, Sanwa Kagaku Co. Ltd., Urovant Sciences Inc, Serenity Pharmaceuticals LLC, Vantia Therapeutics Inc, AA Pharma Inc, Wellesley Pharmaceuticals Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/nocturia-global-market-report

Which Regions Are Poised For Strategic Growth In The Nocturia Market?

North America was the largest region in the nocturia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nocturia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Nocturia Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21232&type=smp

Browse Through More Reports Similar to the Global Nocturia Market 2026, By The Business Research Company

Urinary Incontinence Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-incontinence-global-market-report

Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Nephrology And Urology Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/nephrology-and-urology-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795